Topics

Merck Raises 2019 Non-GAAP EPS Guidance Range

07:31 EDT 29 Oct 2019 | FinanzNachrichten

KENILWORTH (NJ) (dpa-AFX) - Merck (MRK) narrowed and raised 2019 non-GAAP earnings per share guidance range to be between $5.12 and $5.17. Full-year revenue outlook range was narrowed and increase...

Original Article: Merck Raises 2019 Non-GAAP EPS Guidance Range

NEXT ARTICLE

More From BioPortfolio on "Merck Raises 2019 Non-GAAP EPS Guidance Range"

Quick Search

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...